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background:  In the Randomized Trial of Preventive Angioplasty in Myocardial Infarction (PRAMI; ISRCTN73028481), compared with 
infarct-related artery (IRA)-only PCI, additional immediate multivessel PCI (MV-PCI) of non-IRA improved long term prognosis. We studied 
left ventricular (LV) outcomes in a pre-specified cardiac magnetic resonance (CMR) sub-study.
methods:  In a single centre prospective sub-study, PRAMI participants were invited to undergo 1.5T CMR 1 week and 1 year after 
primary PCI. LV analysis was performed using semi-automated software by a clinician blinded to treatment group assignment and clinical 
outcomes. Data was analysed byan independent statistician.
results:  Of 465 randomised trial participants in 6 UK hospitals, 138 (30%) were enrolled in Glasgow. Eighty patients (17%) (mean age 
60 years, 76% male) underwent CMR initially (n=41 (51%) in the multi-vessel PCI group; n=39 (49%) in the IRA-only group). 69 (86%) of 
these patients had a follow up CMR scan at 1 year (n=7 lost to follow-up, n=4 deceased). See Table 1 for results.
Conclusion:  The CMR sub-study participants represented the majority of all randomised participants in our hospital, which included 
one third of the PRAMI trial population. LV function and volumes were similar at 1 week and 1 year post-intervention in survivors. The 
CMR sub-study suggests that the benefit of the preventive PCI strategy in PRAMI may not be mediated by any effects on LV function and 
remodelling.
Table 1. LVEF and volumes in PRAMI trial participants (n=80) in Glasgow.
All values are mean (SD) Infarct-only PCIn=39 (49%)
Multivessel PCI
n=41 (51%) p
1 week post-MI 
LVEF, % 47.4 (10.8) 46.7 (11.7) 0.31
LVEDVi, ml/m2 68.4 (15.6) 67.0 (16.9) 0.84
LVESVi, ml/m2 37.2 (6.6) 37.9 (15.8) 0.24
Change from baseline at 1 year
ΔLVEF, % 6.1 (8.9) 5.2 (11.4) 0.22
ΔLVEDVi, ml/m2 -3.8 (14.7) 0.7 (12.7) 0.27
ΔLVESVi, ml/m2 -6.6 (10.9) -3.1 (10.4) 0.38
